Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.26
(-3.4%)
CNY 4.26
(-3.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.06 Billion CNY | -27.79% |
| 2022 | 1.46 Billion CNY | -18.07% |
| 2021 | 1.79 Billion CNY | -33.37% |
| 2020 | 2.69 Billion CNY | -38.16% |
| 2019 | 4.35 Billion CNY | -16.78% |
| 2018 | 5.22 Billion CNY | 7.36% |
| 2017 | 4.86 Billion CNY | -5.17% |
| 2016 | 5.13 Billion CNY | 49.13% |
| 2015 | 3.44 Billion CNY | 79.89% |
| 2014 | 1.91 Billion CNY | 468.26% |
| 2013 | 336.78 Million CNY | -9.01% |
| 2012 | 370.13 Million CNY | -12.18% |
| 2011 | 421.44 Million CNY | -10.59% |
| 2010 | 471.37 Million CNY | -39.94% |
| 2009 | 784.8 Million CNY | -20.67% |
| 2008 | 989.23 Million CNY | 21.47% |
| 2007 | 814.38 Million CNY | -0.98% |
| 2006 | 822.47 Million CNY | -2.1% |
| 2005 | 840.14 Million CNY | -5.55% |
| 2004 | 889.55 Million CNY | -9.51% |
| 2003 | 983.01 Million CNY | 13.42% |
| 2002 | 866.67 Million CNY | 39.59% |
| 2001 | 620.88 Million CNY | -11.04% |
| 2000 | 697.92 Million CNY | 0.86% |
| 1999 | 691.94 Million CNY | 46.24% |
| 1998 | 473.15 Million CNY | 257.87% |
| 1997 | 132.21 Million CNY | 0.51% |
| 1996 | 131.54 Million CNY | 98.31% |
| 1995 | 66.33 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.02 Billion CNY | 0.58% |
| 2024 Q1 | 1.09 Billion CNY | 3.73% |
| 2024 Q2 | 1.01 Billion CNY | -7.42% |
| 2023 Q4 | 1.06 Billion CNY | -26.14% |
| 2023 Q3 | 1.43 Billion CNY | -1.76% |
| 2023 Q2 | 1.46 Billion CNY | -0.87% |
| 2023 FY | 1.06 Billion CNY | -27.79% |
| 2023 Q1 | 1.47 Billion CNY | 0.39% |
| 2022 Q3 | 1.62 Billion CNY | -3.35% |
| 2022 Q4 | 1.46 Billion CNY | -9.72% |
| 2022 FY | 1.46 Billion CNY | -18.07% |
| 2022 Q1 | 1.68 Billion CNY | -5.8% |
| 2022 Q2 | 1.68 Billion CNY | -0.32% |
| 2021 Q4 | 1.79 Billion CNY | -27.08% |
| 2021 Q1 | 2.6 Billion CNY | -3.31% |
| 2021 FY | 1.79 Billion CNY | -33.37% |
| 2021 Q2 | 2.51 Billion CNY | -3.37% |
| 2021 Q3 | 2.45 Billion CNY | -2.2% |
| 2020 Q3 | 3.97 Billion CNY | -1.97% |
| 2020 Q1 | 4.37 Billion CNY | 0.46% |
| 2020 Q2 | 4.05 Billion CNY | -7.17% |
| 2020 Q4 | 2.69 Billion CNY | -32.36% |
| 2020 FY | 2.69 Billion CNY | -38.16% |
| 2019 Q3 | 5.74 Billion CNY | 8.84% |
| 2019 Q1 | 5.16 Billion CNY | -1.21% |
| 2019 FY | 4.35 Billion CNY | -16.78% |
| 2019 Q4 | 4.35 Billion CNY | -24.25% |
| 2019 Q2 | 5.27 Billion CNY | 2.18% |
| 2018 Q4 | 5.22 Billion CNY | 3.82% |
| 2018 FY | 5.22 Billion CNY | 7.36% |
| 2018 Q2 | 4.77 Billion CNY | 3.65% |
| 2018 Q1 | 4.6 Billion CNY | -5.47% |
| 2018 Q3 | 5.03 Billion CNY | 5.54% |
| 2017 Q2 | 5.17 Billion CNY | 2.34% |
| 2017 Q1 | 5.06 Billion CNY | -1.43% |
| 2017 FY | 4.86 Billion CNY | -5.17% |
| 2017 Q4 | 4.86 Billion CNY | -6.3% |
| 2017 Q3 | 5.19 Billion CNY | 0.32% |
| 2016 Q1 | 3.97 Billion CNY | 15.57% |
| 2016 Q3 | 3.95 Billion CNY | 1.1% |
| 2016 Q2 | 3.91 Billion CNY | -1.65% |
| 2016 Q4 | 5.13 Billion CNY | 29.78% |
| 2016 FY | 5.13 Billion CNY | 49.13% |
| 2015 Q1 | 3.06 Billion CNY | 60.11% |
| 2015 Q3 | 3.15 Billion CNY | 3.58% |
| 2015 FY | 3.44 Billion CNY | 79.89% |
| 2015 Q2 | 3.04 Billion CNY | -0.5% |
| 2015 Q4 | 3.44 Billion CNY | 9.01% |
| 2014 FY | 1.91 Billion CNY | 468.26% |
| 2014 Q1 | 353.95 Million CNY | 5.1% |
| 2014 Q2 | 351.02 Million CNY | -0.83% |
| 2014 Q3 | 346.77 Million CNY | -1.21% |
| 2014 Q4 | 1.91 Billion CNY | 451.89% |
| 2013 Q3 | 363.39 Million CNY | -0.96% |
| 2013 Q1 | 366.09 Million CNY | -1.09% |
| 2013 Q2 | 366.91 Million CNY | 0.22% |
| 2013 Q4 | 336.78 Million CNY | -7.32% |
| 2013 FY | 336.78 Million CNY | -9.01% |
| 2012 FY | 370.13 Million CNY | -12.18% |
| 2012 Q4 | 370.13 Million CNY | -6.51% |
| 2012 Q3 | 395.91 Million CNY | -0.48% |
| 2012 Q2 | 397.82 Million CNY | -4.11% |
| 2012 Q1 | 414.87 Million CNY | -1.56% |
| 2011 FY | 421.44 Million CNY | -10.59% |
| 2011 Q1 | 465.06 Million CNY | -1.34% |
| 2011 Q2 | 453.97 Million CNY | -2.39% |
| 2011 Q4 | 421.44 Million CNY | -2.93% |
| 2011 Q3 | 434.18 Million CNY | -4.36% |
| 2010 Q3 | 501.48 Million CNY | -5.48% |
| 2010 FY | 471.37 Million CNY | -39.94% |
| 2010 Q4 | 471.37 Million CNY | -6.0% |
| 2010 Q2 | 530.54 Million CNY | 0.92% |
| 2010 Q1 | 525.7 Million CNY | -33.01% |
| 2009 Q3 | 959.83 Million CNY | -3.79% |
| 2009 FY | 784.8 Million CNY | -20.67% |
| 2009 Q4 | 784.8 Million CNY | -18.24% |
| 2009 Q1 | 978.89 Million CNY | -1.05% |
| 2009 Q2 | 997.61 Million CNY | 1.91% |
| 2008 Q3 | 884.87 Million CNY | -0.03% |
| 2008 FY | 989.23 Million CNY | 21.47% |
| 2008 Q1 | 838.21 Million CNY | 2.93% |
| 2008 Q2 | 885.11 Million CNY | 5.6% |
| 2008 Q4 | 989.23 Million CNY | 11.79% |
| 2007 Q3 | 845.01 Million CNY | 6.05% |
| 2007 Q2 | 796.81 Million CNY | -3.4% |
| 2007 Q4 | 814.38 Million CNY | -3.62% |
| 2007 FY | 814.38 Million CNY | -0.98% |
| 2007 Q1 | 824.85 Million CNY | 0.29% |
| 2006 Q3 | 796.43 Million CNY | -3.44% |
| 2006 Q1 | 825.75 Million CNY | -1.71% |
| 2006 FY | 822.47 Million CNY | -2.1% |
| 2006 Q4 | 822.47 Million CNY | 3.27% |
| 2006 Q2 | 824.84 Million CNY | -0.11% |
| 2005 Q4 | 840.14 Million CNY | -1.76% |
| 2005 Q3 | 855.16 Million CNY | 0.24% |
| 2005 Q2 | 853.09 Million CNY | -0.94% |
| 2005 Q1 | 861.18 Million CNY | -3.19% |
| 2005 FY | 840.14 Million CNY | -5.55% |
| 2004 Q3 | 866.83 Million CNY | -0.37% |
| 2004 Q1 | 833.23 Million CNY | -15.24% |
| 2004 FY | 889.55 Million CNY | -9.51% |
| 2004 Q2 | 870.02 Million CNY | 4.42% |
| 2004 Q4 | 889.55 Million CNY | 2.62% |
| 2003 Q3 | 867.22 Million CNY | -1.69% |
| 2003 Q2 | 882.15 Million CNY | -0.1% |
| 2003 FY | 983.01 Million CNY | 13.42% |
| 2003 Q4 | 983.01 Million CNY | 13.35% |
| 2003 Q1 | 883 Million CNY | 1.88% |
| 2002 Q2 | 718.82 Million CNY | 2.54% |
| 2002 FY | 866.67 Million CNY | 39.59% |
| 2002 Q1 | 701.01 Million CNY | 12.91% |
| 2002 Q3 | 763.75 Million CNY | 6.25% |
| 2002 Q4 | 866.67 Million CNY | 13.47% |
| 2001 FY | 620.88 Million CNY | -11.04% |
| 2001 Q4 | 620.88 Million CNY | 0.0% |
| 2001 Q2 | 669.16 Million CNY | 0.0% |
| 2000 Q4 | 697.92 Million CNY | 0.0% |
| 2000 FY | 697.92 Million CNY | 0.86% |
| 2000 Q2 | 678.48 Million CNY | 0.0% |
| 1999 Q2 | 492.13 Million CNY | 0.0% |
| 1999 FY | 691.94 Million CNY | 46.24% |
| 1999 Q4 | 691.94 Million CNY | 0.0% |
| 1998 FY | 473.15 Million CNY | 257.87% |
| 1998 Q4 | 473.15 Million CNY | 0.0% |
| 1997 FY | 132.21 Million CNY | 0.51% |
| 1996 FY | 131.54 Million CNY | 98.31% |
| 1995 FY | 66.33 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | 92.376% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | 64.468% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 3.02 Billion CNY | 64.999% |
| Yifan Pharmaceutical Co., Ltd. | 11.49 Billion CNY | 90.779% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -25.105% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 36.52 Billion CNY | 97.097% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 2.89 Billion CNY | 63.321% |
| Boai NKY Medical Holdings Ltd. | 4.01 Billion CNY | 73.621% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | 58.615% |